"we had (borrelia miyamotoi) as the new disease for the physicians to be aware of", told rusk...
despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6...
harvard medical school: "cgrp: a new era for migraine treatment.".